Adrib 50mg Injection
Marketer
Adley Formulations
Salt Composition
Doxorubicin (Liposomal) (50mg)
Overview Adrib 50mg Injection
Fifty milligram Adrib injections treat various cancers, including high-risk breast cancer. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy for adults and children. Dosage and frequency vary depending on the condition and are determined by your physician. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can cause severe adverse reactions. Benefits may take weeks or months to appear; discontinue only under medical guidance. Because it reduces contraceptive effectiveness, reliable birth control is recommended for six months post-treatment. Common side effects include nausea, vomiting, rash, weakness, and thrombocytopenia; report persistent or worsening symptoms. While potent and potentially causing serious adverse reactions like hematological, hepatic, or cardiac issues, regular blood tests will monitor these risks. Pre-existing liver conditions and all other medications should be disclosed to your doctor before commencing treatment, as interactions can affect Adrib's efficacy. Inform your doctor of pregnancy or breastfeeding.
Uses of Adrib 50mg Injection
Malignant neoplasm
Major Benefits of Adrib 50mg Injection:
Administering this medication requires a healthcare professional (doctor or nurse). Self-medication is strongly discouraged.
Common Side effects of Adrib 50mg Injection:
- Nausea
- Vomiting
- Rash
- Weakness
- Low blood platelets
- Fatigue
- Fever
- Decreased white blood cell count (neutrophils)
- Loss of appetite
- Anemia (low number of red blood cells)
- Constipation
- Stomatitis (Inflammation of the mouth)
- Diarrhea
- Painful blisters on hands and feet
How to use Adrib 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Adrib 50mg Injection works:
Oncaspar 50mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting the DNA of malignant cells, thereby inhibiting their proliferation and expansion.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Adrib 50mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Adrib 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Data on Adrib 50mg Injection use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Administering Adrib 50mg Injection might cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is discouraged if these side effects manifest.
KidneySAFE IF PRESCRIBED
Adrib 50mg Injection can be administered to patients with kidney disease without altering the dosage. However, patients with severely impaired kidney function should be carefully monitored, as limited data exists regarding Adrib 50mg Injection use in this population.
LiverCAUTION
Patients with liver impairment should use Adrib 50mg Injection cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Adrib 50mg Injection; physician consultation is advised.
What if you forget to take Adrib 50mg Injection :
NA
Facts to Know About Adrib 50mg Injection
| Label | Value |
|---|---|
| Type of Compound | Anthracycline-based drug |
| Addictive | None. |
| Medication Classification | Cancer therapeutics |
| Mechanism of Action | Plant-derived anti-cancer compounds |
3,018 People bought this recently